Filing Details

Accession Number:
0000899243-23-009465
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-22 21:00:07
Reporting Period:
2023-03-20
Accepted Time:
2023-03-22 21:00:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1635088 Roivant Sciences Ltd. ROIV Pharmaceutical Preparations (2834) 981173944
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1699940 L.p. Fund Vision Softbank Aztec Group House 11-15 Seaton Place
St. Helier Y9 JE4 0QH
No No Yes No
1716727 Llp (Uk) Holdings Svf 69 Grosvenor Street
London X0 W1K 3JP
No No Yes No
1716729 Ltd (Uk) Investments Svf 69 Grosvenor Street
London X0 W1K 3JP
No No Yes No
1731509 Ltd (Uk) Advisers Investment Sb 69 Grosvenor Street
London X0 W1K 3JP
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2023-03-20 12,000,000 $8.00 83,031,667 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. Securities held of record by SVF Investments (UK) Limited ("SVF Investments"). Softbank Vision Fund L.P. is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments. SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as the alternative investment fund manager ("AIFM") of SoftBank Vision Fund L.P. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund L.P.'s investments.